Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
ICAM2 N/A
Sequence Length (AA) Molecular Weight (Da)
275 30654
Protein Name
Intercellular adhesion molecule 2
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MSSFGYRTLT VALFTLICCP GSDEKVFEVH VRPKKLAVEP KGSLEVNCST
60 70 80 90 100
TCNQPEVGGL ETSLDKILLD EQAQWKHYLV SNISHDTVLQ CHFTCSGKQE
110 120 130 140 150
SMNSNVSVYQ PPRQVILTLQ PTLVAVGKSF TIECRVPTVE PLDSLTLFLF
160 170 180 190 200
RGNETLHYET FGKAAPAPQE ATATFNSTAD REDGHRNFSC LAVLDLMSRG
210 220 230 240 250
GNIFHKHSAP KMLEIYEPVS DSQMVIIVTV VSVLLSLFVT SVLLCFIFGQ
260 270 275
HLRQQRMGTY GVRAAWRRLP QAFRP

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-677 Collapse assay details

Data source: Panorama

Official Gene Symbol
ICAM2
Peptide Modified Sequence
AAPAPQEATATFN[+1.0]STADR
Modification Type
Deamidated (NQ)
Protein - Site of Modification
176
Peptide - Site of Modification
13
Peptide Start
164
Peptide End
181
CPTAC ID
CPTAC-677
Peptide Molecular Mass
1,818.8384
Species
Homo sapiens (Human)
Assay Type
Enrichment PRM
Enrichment Method
N-linked glycopeptide solid phase extraction
Matrix
serum
Submitting Laboratory
Johns Hopkins University
Submitting Lab PI
Daniel Chan, Hui Zhang, Zhen Zhang

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Q-Exactive (ThermoFisher)
Internal Standard
synthetic peptide
Peptide Standard Purity
Crude
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Dionex UltiMate 3000 RSLCnano LC (ThermoFisher)
Column Packing
Acclaim PepMap100 C18, 5um (Trap); Acclaim PepMap RSLC C18, 2um (Analytical)
Column Dimensions
300um x 5mm (Trap); 75um x 25cm (Analytical)
Flow Rate
0.5 uL/min

Assay Multiplexing Expand assay panel

Johns Hopkins University-A

CPTAC-648:
APMAP.
AGPN[+1.0]GTLFVADAYK
CPTAC-649:
AFM.
DIENFN[+1.0]STQK
CPTAC-650:
AFM.
FN[+1.0]ETTEK
CPTAC-651:
SERPINA1.
YLGN[+1.0]ATAIFFLPDEGK
CPTAC-652:
APOB.
FN[+1.0]SSYLQGTNQITGR
CPTAC-653:
APOB.
YDFN[+1.0]SSM[+16.0]LYSTAK
CPTAC-654:
APOH.
VYKPSAGN[+1.0]NSLYR
CPTAC-655:
BTD.
FN[+1.0]DTEVLQR
CPTAC-656:
CDH13.
IN[+1.0]NTHALVSLLQNLNK
CPTAC-657:
CPB2.
QVHFFVN[+1.0]ASDVDNVK
CPTAC-658:
CTSD.
GSLSYLN[+1.0]VTR
CPTAC-659:
JCHAIN.
EN[+1.0]ISDPTSPLR
CPTAC-660:
CP.
EHEGAIYPDN[+1.0]TTDFQR
CPTAC-661:
CLU.
EDALN[+1.0]ETR
CPTAC-662:
CLU.
LAN[+1.0]LTQGEDQYYLR
CPTAC-663:
DKFZp779M0311.
QSVPAHFVALN[+1.0]GSK
CPTAC-664:
ATRN.
IDSTGN[+1.0]VTNELR
CPTAC-665:
C4A.
FSDGLESN[+1.0]SSTQFEVK
CPTAC-666:
C4A.
GLN[+1.0]VTLSSTGR
CPTAC-667:
C8A.
GGSSGWSGGLAQN[+1.0]R
CPTAC-668:
CD44.
AFN[+1.0]STLPTM[+16.0]AQM[+16.0]EK
CPTAC-669:
IGHG1.
EEQYN[+1.0]STYR
CPTAC-670:
LGALS3BP.
ALGFEN[+1.0]ATQALGR
CPTAC-671:
HP.
VVLHPN[+1.0]YSQVDIGLIK
CPTAC-672:
SERPINA4.
FLN[+1.0]DTM[+16.0]AVYEAK
CPTAC-673:
IGHG4.
EEQFN[+1.0]STYR
CPTAC-674:
IGHA2.
TPLTAN[+1.0]ITK
CPTAC-675:
IGHG2.
EEQFN[+1.0]STFR
CPTAC-676:
ITIH2.
GAFISN[+1.0]FSM[+16.0]TVDGK
CPTAC-677:
ICAM2.
AAPAPQEATATFN[+1.0]STADR
CPTAC-678:
LRG1.
LPPGLLAN[+1.0]FTLLR
CPTAC-679:
LYVE1.
ANQQLN[+1.0]FTEAK
CPTAC-680:
TIMP1.
FVGTPEVN[+1.0]QTTLYQR
CPTAC-681:
LCN2.
SYN[+1.0]VTSVLFR
CPTAC-682:
KLKB1.
IYPGVDFGGEELN[+1.0]VTFVK
CPTAC-683:
KLKB1.
IYSGILN[+1.0]LSDITK
CPTAC-684:
SERPING1.
DTFVN[+1.0]ASR
CPTAC-685:
PIGR.
VPGN[+1.0]VTAVLGETLK
CPTAC-686:
PTGDS.
SVVAPATDGGLN[+1.0]LTSTFLR
CPTAC-687:
KNG1.
LNAENN[+1.0]ATFYFK
CPTAC-688:
LAMP2.
LN[+1.0]SSTIK
CPTAC-689:
LAMP2.
VQPFN[+1.0]VTQGK
CPTAC-690:
VTN.
N[+1.0]GSLFAFR

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y12 (1+) 15.4 18.7 19.4 15 17.7 20.8 21.5 25.7 28.4 15 15 15
y10 (1+) 14.1 15.6 17.9 14.9 14.4 15.7 20.5 21.2 23.8 15 15 15
y8 (1+) 23.3 20.5 20.9 32.5 34.7 26.6 40 40.3 33.8 15 15 15
sum 6.7 12.2 12.3 7.6 16.3 12.8 10.1 20.4 17.8 15 15 15


Additional Resources and Comments


Assay Details for non-CPTAC-3315 Collapse assay details

Data source: Panorama

Official Gene Symbol
Icam2
Peptide Sequence
LTLSLLR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
144
Peptide End
151
CPTAC ID
non-CPTAC-3315
Peptide Molecular Mass
814.5276
Species
Mus musculus (Mouse)
Assay Type
Direct PRM
Matrix
Plasma
Submitting Laboratory
UVic-Genome BC Proteomics Centre
Submitting Lab PI
Christoph Borchers

Publication

View Details (opens in a new window)

Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y Eshghi A1, Richard VR, Sickmann A, Borchers CH. Commun Biol. 2018 Jun 27;1:78. doi: 10.1038/s42003-018-0087-6. eCollection 2018.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Agilent 6490/6495 QQQ
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
LC
1290 LC (Agilent)
Column Packing
Zorbax Eclipse Plus C18, 1.8 µm
Column Dimensions
2.1 x 150 mm
Flow Rate
400 µL/min

Assay Multiplexing Expand assay panel

Johns Hopkins University-A

CPTAC-648:
APMAP.
AGPN[+1.0]GTLFVADAYK
CPTAC-649:
AFM.
DIENFN[+1.0]STQK
CPTAC-650:
AFM.
FN[+1.0]ETTEK
CPTAC-651:
SERPINA1.
YLGN[+1.0]ATAIFFLPDEGK
CPTAC-652:
APOB.
FN[+1.0]SSYLQGTNQITGR
CPTAC-653:
APOB.
YDFN[+1.0]SSM[+16.0]LYSTAK
CPTAC-654:
APOH.
VYKPSAGN[+1.0]NSLYR
CPTAC-655:
BTD.
FN[+1.0]DTEVLQR
CPTAC-656:
CDH13.
IN[+1.0]NTHALVSLLQNLNK
CPTAC-657:
CPB2.
QVHFFVN[+1.0]ASDVDNVK
CPTAC-658:
CTSD.
GSLSYLN[+1.0]VTR
CPTAC-659:
JCHAIN.
EN[+1.0]ISDPTSPLR
CPTAC-660:
CP.
EHEGAIYPDN[+1.0]TTDFQR
CPTAC-661:
CLU.
EDALN[+1.0]ETR
CPTAC-662:
CLU.
LAN[+1.0]LTQGEDQYYLR
CPTAC-663:
DKFZp779M0311.
QSVPAHFVALN[+1.0]GSK
CPTAC-664:
ATRN.
IDSTGN[+1.0]VTNELR
CPTAC-665:
C4A.
FSDGLESN[+1.0]SSTQFEVK
CPTAC-666:
C4A.
GLN[+1.0]VTLSSTGR
CPTAC-667:
C8A.
GGSSGWSGGLAQN[+1.0]R
CPTAC-668:
CD44.
AFN[+1.0]STLPTM[+16.0]AQM[+16.0]EK
CPTAC-669:
IGHG1.
EEQYN[+1.0]STYR
CPTAC-670:
LGALS3BP.
ALGFEN[+1.0]ATQALGR
CPTAC-671:
HP.
VVLHPN[+1.0]YSQVDIGLIK
CPTAC-672:
SERPINA4.
FLN[+1.0]DTM[+16.0]AVYEAK
CPTAC-673:
IGHG4.
EEQFN[+1.0]STYR
CPTAC-674:
IGHA2.
TPLTAN[+1.0]ITK
CPTAC-675:
IGHG2.
EEQFN[+1.0]STFR
CPTAC-676:
ITIH2.
GAFISN[+1.0]FSM[+16.0]TVDGK
CPTAC-677:
ICAM2.
AAPAPQEATATFN[+1.0]STADR
CPTAC-678:
LRG1.
LPPGLLAN[+1.0]FTLLR
CPTAC-679:
LYVE1.
ANQQLN[+1.0]FTEAK
CPTAC-680:
TIMP1.
FVGTPEVN[+1.0]QTTLYQR
CPTAC-681:
LCN2.
SYN[+1.0]VTSVLFR
CPTAC-682:
KLKB1.
IYPGVDFGGEELN[+1.0]VTFVK
CPTAC-683:
KLKB1.
IYSGILN[+1.0]LSDITK
CPTAC-684:
SERPING1.
DTFVN[+1.0]ASR
CPTAC-685:
PIGR.
VPGN[+1.0]VTAVLGETLK
CPTAC-686:
PTGDS.
SVVAPATDGGLN[+1.0]LTSTFLR
CPTAC-687:
KNG1.
LNAENN[+1.0]ATFYFK
CPTAC-688:
LAMP2.
LN[+1.0]SSTIK
CPTAC-689:
LAMP2.
VQPFN[+1.0]VTQGK
CPTAC-690:
VTN.
N[+1.0]GSLFAFR

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
b2 (1+) 5.7 4.8 4.4 12.8 9 4.8 14 10.2 6.5 15 15 15
y4 (1+) 6.4 4.7 3.7 12.3 7.5 5.5 13.9 8.9 6.6 15 15 15
y3 (2+) 114.4 86.4 64.2 132.1 123.8 57.4 174.8 151 86.1 15 15 15
y5 (1+) 5.3 2.4 3.3 13.4 7.8 4.2 14.4 8.2 5.3 15 15 15
y6 (1+) 8.1 7.2 5.3 13.3 9.9 9.3 15.6 12.2 10.7 15 15 15
sum 1.8 1.6 1.6 11.9 7.4 3.9 12 7.6 4.2 15 15 15


Additional Resources and Comments